An exaggerated emotional brain response to nonthreatening, nonemotional cues at age 14 predicted the onset of psychosis symptoms within the next 2 years.
Researchers evaluated data from acute respiratory distress syndrome patients to see if it was possible to anticipate which ones would develop psychiatric symptoms.
RP5063, a dopamine serotonin stabilizer, was associated with symptom improvement in adults with acute exacerbation of schizophrenia or schizoaffective disorder.
Researchers sought to determine if functional magnetic resonance imaging could be used to predict treatment response in patients with major depressive disorder.